CDKN2A and nonpapillary renal cell carcinoma: Similarly, expression levels of FDX1, DLD, DIAT, and PDHB were much more abundant in alive ccRCC patients than those in dead controls, while the expression levels of CDKN2A and MTF1 were oppositely presented in this profile.